# Thymulin FAQ: Plain Answers from the Research Literature

> Thymulin FAQ - what it is, the nonapeptide sequence, why it needs zinc, gene therapy, dosing in studies, and how it differs from thymosin alpha-1. Cited answers.

Short, cited answers to the most common thymulin questions - identity, zinc dependence, gene therapy, and the human-data gaps.

## What is thymulin?

Thymulin is a zinc-dependent thymic nonapeptide hormone produced exclusively by thymic epithelial cells; it is biologically active only when bound to zinc in a 1:1 ratio [1][2]. It is studied as a research peptide across immune, anti-inflammatory, and neuroendocrine models, and it is not FDA-approved for any use.

## What is thymulin peptide?

Thymulin is a linear nonapeptide with the sequence pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn that becomes biologically active only after binding one zinc ion per molecule [1][2]. Its molecular formula is C33H54N12O15 and its molecular weight is about 858.86 Da. The zinc-free apopeptide is inactive.

## Is thymulin the same as serum thymic factor (FTS)?

Yes in lineage. Serum thymic factor (FTS) is the original name for the same peptide; FTS denotes the zinc-free peptide, and once zinc binds in a 1:1 ratio the active form was named thymulin (FTS-Zn) [1]. They are two states of one molecule: the inactive apo form and the active zinc-loaded form.

## What is the amino acid sequence of thymulin?

Thymulin is the nonapeptide pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (written <Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn), with molecular formula C33H54N12O15 [2]. The pyroGlu at the start is a cyclized glutamate residue. This exact sequence is what distinguishes thymulin from other thymic peptides.

## Why does thymulin need zinc to work?

Binding one zinc ion per peptide drives a specific active conformation; the zinc-free apopeptide is inactive [2]. In the original work, chelating zinc abolished activity and adding zinc back restored it at a 1:1 metal-to-peptide ratio [1]. Zinc organizes the active shape - it is the switch, not an optional extra.

## What does thymulin do in the body?

Endogenously, thymulin contributes to T-lymphocyte differentiation and immune-cell modulation and acts as a hypophysiotropic peptide in a bidirectional thymus-neuroendocrine axis [4]. Circulating levels peak in childhood and decline with age and zinc deficiency [4][14]. Its level tracks both thymic function and the body's zinc status.

## What are the benefits of thymulin peptide?

In research models, thymulin has shown anti-inflammatory, immune-modulating, anti-hyperalgesic, and - via gene therapy - lung-protective effects [6][7]. All are study findings in named species or in-vitro systems, not demonstrated human benefits. There is no clinical benefit established for people.

## What are the benefits of thymulin?

Documented research effects include suppression of pro-inflammatory cytokines and NF-kB signaling, reduced inflammatory hyperalgesia, and immunomodulation in autoimmune and metabolic models, all in animals or cells [6][9]. The endogenous role adds T-cell differentiation [4]. These are model findings, never a human treatment claim.

## Does thymulin boost the immune system?

Thymulin's classical role is driving T-cell differentiation and modulating immune-cell function [4]; in zinc-deficiency and aging models, restoring zinc-bound thymulin was associated with improved immune measures [3][14]. This is research-model evidence, not a clinical immune-boosting claim, and the effects are entangled with zinc status.

## Does thymulin reduce inflammation?

In LPS, septic, autoimmune, and diabetic mouse models, thymulin was associated with lower pro-inflammatory cytokines and reduced NF-kB and SAPK/JNK signaling [6]. These are animal and in-vitro findings describing what thymulin did in those models, not an anti-inflammatory treatment effect demonstrated in humans.

## Can thymulin help with autoimmune disease?

In rodent experimental autoimmune encephalomyelitis (a multiple-sclerosis model), thymulin reduced disease severity and, with peroxiredoxin 6, supported blood-brain-barrier integrity [9][11]. These are preclinical results in mice, not evidence of treatment in people, and no autoimmune indication is established.

## Does thymulin have anti-aging effects?

Circulating thymulin declines with age and zinc deficiency; in aged mice, zinc repletion was linked to restored thymulin secretion and thymic function [14]. This frames thymulin within zinc-dependent immunosenescence research, not as an anti-aging therapy for humans. Gene therapy to restore it is experimental [5].

## Is thymulin studied for pain relief?

In rodent inflammatory and endotoxin models, thymulin and its analog PAT produced dose-dependent reductions in hyperalgesia with a biphasic profile; thymulin alone did not change baseline pain [4]. These are animal findings only, with no established human pain indication.

## What is thymulin gene therapy?

An experimental strategy that uses adenoviral or nanoparticle vectors carrying a thymulin-encoding gene to restore sustained circulating thymulin in animal models, developed because the native peptide has a short circulating half-life [5][7]. It is preclinical - studied in mice and rats, not offered to people.

## Has thymulin been studied for asthma?

In a mouse model of established allergic asthma, a single inhaled dose of thymulin-expressing plasmid in mucus-penetrating nanoparticles normalized key lung pathologies at 20 days [7]; a separate DNA-nanoparticle study reported prevention of airway remodeling [12]. These are animal findings, not human treatment.

## How is thymulin different from thymosin alpha-1?

They are distinct thymic peptides. Thymulin is a zinc-dependent nonapeptide; thymosin alpha-1 is a separate, larger peptide with its own research literature [1][2]. Thymulin's findings should never be attributed to thymosin alpha-1, to thymosin beta-4 (TB-500), or to thymalin (a bovine thymic complex).

## How is thymulin administered in research?

In animal and in-vitro studies thymulin has been given by intraperitoneal, subcutaneous, and intracerebroventricular routes, with intratracheal and intramuscular delivery used for gene-therapy vectors and a topical zinc-thymulin pilot in humans [5][7]. There is no approved human route of administration.

## What is the dosage of thymulin peptide?

There is no established human dose. Studies report research doses in animals - for example nanogram-to-low-microgram amounts intraperitoneally or intracerebroventricularly - and these are study parameters, not protocols for people [4]. Gene-therapy work used a single vector dose rather than a peptide dose [5].

## Is thymulin taken as an injection?

In research, thymulin has been delivered by injection routes (intraperitoneal, subcutaneous, intracerebroventricular) in animals; a human topical zinc-thymulin pilot used a skin formulation [7]. There is no approved human injectable product, and the literature describes experimental routes only.

## What doses of thymulin were used in animal studies?

Reported research doses include 0.1-1 microg intracerebroventricularly and 1-1000 ng intraperitoneally in rodent pain models, and roughly 100 ng/kg/day subcutaneously in a rat pulmonary-hypertension study; a mouse study used 50 microg per animal of serum thymic factor [4][15]. Gene-therapy work used a single vector dose rather than a peptide dose [5].

## Is there a thymulin supplement?

Thymulin is a research peptide, not an FDA-approved drug and not a dietary supplement [5]. Consumer sources sometimes confuse it with thymosin alpha-1 or with thymalin (a bovine thymic complex); those are different compounds. No legitimate thymulin dietary supplement is established.

## What is the half-life of thymulin?

As a small peptide, native thymulin has a short circulating half-life, but a precise human pharmacokinetic half-life is not well established in the public literature [5] - one reason gene-therapy approaches were developed to sustain circulating levels. The honest answer is that the human half-life is uncharacterized.

---

A deep-water field atlas of the thymulin literature - the zinc-bound thymic peptide catalogued like a vanishing species, the established findings pressed beside the human-data gaps and the molecule kept distinct from thymosin alpha-1 and thymalin; no clinic behind the specimen sheet and nothing here dosed, prescribed, or sold.